Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: U.S.

Vanguard Health Care Fund

+ Add to Watchlist

VGHAX:US

99.26 USD 0.27 0.27%

As of 09:29:30 ET on 05/28/2015.

Snapshot for Vanguard Health Care Fund (VGHAX)

Year To Date: +14.01% 3-Month: +6.54% 3-Year: +32.31% 52-Week Range: 75.80 - 99.26
1-Month: +2.32% 1-Year: +32.89% 5-Year: +24.84% Beta vs S5HLTH: 0.92

Mutual Fund Chart for VGHAX

No chart data available.
  • VGHAX:US 99.26
  • 1M
  • 1Y
Interactive VGHAX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for VGHAX

Vanguard Health Care Fund is an open-end fund incorporated in the USA. The Fund's objective is long-term capital appreciation. The Fund invests at least 80% of its assets in the stocks of companies principally engaged in the development, production, or distribution of products and services related to the health care industry.

Inception Date: 11-12-2001 Telephone: 1-610-669-1000
Managers: JEAN MARIE HYNES
Web Site: www.vanguard.com

Fundamentals for VGHAX

NAV (on 2015-05-28) 99.26
Assets (M) (on 2015-04-30) 50,040.64
Fund Leveraged N
Minimum Investment 10,000.00
Minimum Subsequent Investment 100.00

Dividends for VGHAX

Dividend Type Income
Dividend Frequency Annual
Last Dividend Net (on 2015-03-26) 0.35
Dividend Yield (ttm) 10.03

Fees & Expenses for VGHAX

Front Load 0.00
Back Load 0.00
Current Mgmt Fee 0.28
Redemption Fee 0.00
12b1 Fee 0.00
Expense Ratio 0.29

Top Fund Holdings for VGHAX

Filing Date: 03/31/2015
Name Position Value % of Total
Bristol-Myers Squibb Co 42,902,031 2,767,181,000 5.546%
Actavis plc 9,038,107 2,689,921,405 5.391%
UnitedHealth Group Inc 20,519,100 2,427,204,339 4.865%
Merck & Co Inc 40,096,948 2,304,772,571 4.619%
AstraZeneca PLC 27,384,176 1,879,079,660 3.766%
Eli Lilly & Co 24,892,160 1,808,415,424 3.624%
Medtronic PLC 18,885,933 1,472,913,915 2.952%
McKesson Corp 6,342,800 1,434,741,360 2.875%
Regeneron Pharmaceuticals Inc 2,921,000 1,318,773,080 2.643%
Vertex Pharmaceuticals Inc 9,533,911 1,124,715,481 2.254%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil